Abnova (Taiwan) Corporation

TWSE:4133 Stock Report

Market Cap: NT$1.4b

Abnova (Taiwan) Past Earnings Performance

Past criteria checks 0/6

Abnova (Taiwan)'s earnings have been declining at an average annual rate of -8.6%, while the Life Sciences industry saw earnings growing at 10.7% annually. Revenues have been declining at an average rate of 6.8% per year.

Key information

-8.64%

Earnings growth rate

-8.64%

EPS growth rate

Life Sciences Industry Growth5.47%
Revenue growth rate-6.75%
Return on equity-0.091%
Net Margin-0.32%
Last Earnings Update31 Dec 2025

Recent past performance updates

Recent updates

We Think You Should Be Aware Of Some Concerning Factors In Abnova (Taiwan)'s (TWSE:4133) Earnings

Nov 21
We Think You Should Be Aware Of Some Concerning Factors In Abnova (Taiwan)'s (TWSE:4133) Earnings

Abnova (Taiwan) Corporation (TPE:4133) Stock's On A Decline: Are Poor Fundamentals The Cause?

Feb 10
Abnova (Taiwan) Corporation (TPE:4133) Stock's On A Decline: Are Poor Fundamentals The Cause?

Revenue & Expenses Breakdown

How Abnova (Taiwan) makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

TWSE:4133 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 25351-19346
30 Sep 2535529346
30 Jun 25361-79046
31 Mar 25361499142
31 Dec 24355628940
30 Sep 24361598738
30 Jun 24365669036
31 Mar 24372609136
31 Dec 23382448838
30 Sep 23396459041
30 Jun 23404618744
31 Mar 23408688547
31 Dec 22412758849
30 Sep 22401628850
30 Jun 22415489151
31 Mar 22436369551
31 Dec 214512810053
30 Sep 214744010053
30 Jun 214924110454
31 Mar 214713910453
31 Dec 204563710551
30 Sep 204402911450
30 Jun 204051412049
31 Mar 204051312651
31 Dec 19414312855
30 Sep 194071612156
30 Jun 194152611557
31 Mar 194253611358
31 Dec 184264611357
30 Sep 184414411555
30 Jun 184575111655
31 Mar 184655511654
31 Dec 174755911353
30 Sep 174676310853
30 Jun 174535510852
31 Mar 174425111050
31 Dec 164405411049
30 Sep 164494611548
30 Jun 164464711648
31 Mar 164585911348
31 Dec 154514511449
30 Sep 154495811348
30 Jun 154536611445
31 Mar 154415211544

Quality Earnings: 4133 is currently unprofitable.

Growing Profit Margin: 4133 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 4133 is unprofitable, and losses have increased over the past 5 years at a rate of 8.6% per year.

Accelerating Growth: Unable to compare 4133's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 4133 is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (14.4%).

Return on Equity

High ROE: 4133 has a negative Return on Equity (-0.091%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/09 05:57
End of Day Share Price 2026/03/09 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Abnova (Taiwan) Corporation is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xinkai YuMasterlink Securities Corp.